JNK and NF‑κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure
Tóm tắt
Từ khóa
Tài liệu tham khảo
Fahed, 2013, Genetics of congenital heart disease: The glass half empty, Circ Res, 112, 707, 10.1161/CIRCRESAHA.112.300853
Alam, 2016, Congenital heart surgery: Analysis of cases, 130, 30
Khairy, 2010, Changing mortality in congenital heart disease, J Am Coll Cardiol, 56, 1149, 10.1016/j.jacc.2010.03.085
Dolk, 2011, Congenital heart defects in Europe: Prevalence and perinatal mortality, 2000 to 2005, Circulation, 123, 841, 10.1161/CIRCULATIONAHA.110.958405
van der Linde, 2011, Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis, J Am Coll Cardiol, 58, 2241, 10.1016/j.jacc.2011.08.025
Rudan, 2010, Causes of deaths in children younger than 5 years in China in 2008, Lancet, 375, 1083, 10.1016/S0140-6736(10)60060-8
Qu, 2016, Incidence of congenital heart disease: The 9-year experience of the guangdong registry of congenital heart disease, China, PLoS One, 11, e0159257, 10.1371/journal.pone.0159257
Zaidi, 2013, De novo mutations in histone-modifying genes in congenital heart disease, Nature, 498, 220, 10.1038/nature12141
Cole, 2014, Congenital heart disease linked to maternal autoimmunity against cardiac myosin, J Immunol, 192, 4074, 10.4049/jimmunol.1301264
Braunwald, 2000, Congestive heart failure: Fifty years of progress, Circulation, 102, IV14, 10.1161/01.CIR.102.suppl_4.IV-14
Sharma, 2003, Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease, Am J Cardiol, 92, 188, 10.1016/S0002-9149(03)00536-8
Bolger, 2002, Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease, Circulation, 106, 92, 10.1161/01.CIR.0000020009.30736.3F
Tatebe, 2012, Clinical profiles of chronic heart failure with adult congenital heart disease, J Cardiac Failure, 18, S156, 10.1016/j.cardfail.2012.08.163
Afify, 2009, Serum levels of ghrelin, tumor necrosis factor-α and interleukin-6 in infants and children with congenital heart disease, J Trop Pediatr, 55, 388, 10.1093/tropej/fmp036
McMurray, 1991, Increased concentrations of tumour necrosis factor in ‘cachectic’ patients with severe chronic heart failure, Br Heart J, 66, 356, 10.1136/hrt.66.5.356
Torre-Amione, 1996, Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD), J Am Coll Cardiol, 27, 1201, 10.1016/0735-1097(95)00589-7
Ferrari, 1995, Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure, Circulation, 92, 1479, 10.1161/01.CIR.92.6.1479
Kubota, 1997, Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α, Circ Res, 81, 627, 10.1161/01.RES.81.4.627
Borish, 1996, Interleukin-10 regulation in normal subjects and patients with asthma, J Allergy Clin Immunol, 97, 1288, 10.1016/S0091-6749(96)70197-5
Gullestad, 2001, Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure, Circulation, 103, 220, 10.1161/01.CIR.103.2.220
Aukrust, 1999, Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, Am J Cardiol, 83, 376, 10.1016/S0002-9149(98)00872-8
Latorre, 2013, IL-10 modulates serotonin transporter activity and molecular expression in intestinal epithelial cells, Cytokine, 61, 778, 10.1016/j.cyto.2013.01.012
Choi, 2016, c-Jun N-terminal kinase activation has a prognostic implication and is negatively associated with FOXO1 activation in gastric cancer, Bmc Gastroenterol, 16, 59, 10.1186/s12876-016-0473-9
Xu, 2009, A novel hybrid method for creating a porcine model of cyanotic congenital heart defect with decreased pulmonary blood flow, J Surg Res, 154, 262, 10.1016/j.jss.2008.06.024
National Research Council, 2012, Guide for the Care and Use of Laboratory Animals, 8th, 267
Weston, 2007, The JNK signal transduction pathway, Curr Opin Cell Biol, 19, 142, 10.1016/j.ceb.2007.02.001
Liu, 2005, Role of JNK activation in apoptosis: A double-edged sword, Cell Res, 15, 36, 10.1038/sj.cr.7290262
Bogoyevitch, 2006, Uses for JNK: The many and varied substrates of the c-Jun N-terminal kinases, Microbiol Mol Biol Rev, 70, 1061, 10.1128/MMBR.00025-06
Akella, 2008, Unique MAP Kinase binding sites, Biochim Biophys Acta, 1784, 48, 10.1016/j.bbapap.2007.09.016
Brown, 2009, Protein scaffolds in MAP kinase signalling, Cell Signal, 21, 462, 10.1016/j.cellsig.2008.11.013
Monroy, 2011, Hodgkin disease risk: Role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes, Mol Carcinog, 50, 36, 10.1002/mc.20747
Yang, 2011, ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation, Cancer Res, 71, 3688, 10.1158/0008-5472.CAN-10-3445
Karin, 2006, Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer, Cell, 124, 823, 10.1016/j.cell.2006.02.016
Slevin, 2006, Identification of differential protein expression associated with development of unstable human carotid plaques, Am J Pathol, 168, 1004, 10.2353/ajpath.2006.050471
Wilhelm, 2007, Proapoptotic Nix activates the JNK pathway by interacting with POSH and mediates death in a Parkinson disease model, J Biol Chem, 282, 1288, 10.1074/jbc.M607038200
Smith, 2006, Signaling mechanisms underlying Abeta toxicity: Potential therapeutic targets for Alzheimer's disease, Cns Neurol Disord Drug Targets, 5, 355, 10.2174/187152706784111515
Størling, 2005, Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt, Diabetologia, 48, 2039, 10.1007/s00125-005-1912-2
TuncmanGHirosumiJSolinasGChangLKarinMHotamisligilGSFunctional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistanceProc Natl Acad Sci USA1031074110746200610.1073/pnas.060350910316818881
Sen, 2006, Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell, 177, 7485
Deswal, 2001, Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone trial (VEST), Circulation, 103, 2055, 10.1161/01.CIR.103.16.2055
Valen, 2001, Nuclear factor kappa-B and the heart, J Am Coll Cardiol, 38, 307, 10.1016/S0735-1097(01)01377-8
Cohn, 2000, Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling, J Am Coll Cardiol, 35, 569, 10.1016/S0735-1097(99)00630-0
Haudek, 2001, Differential regulation of myocardial NF kappa B following acute or chronic TNF-alpha exposure, J Mol Cell Cardiol, 33, 1263, 10.1006/jmcc.2001.1388
Bradham, 2002, TNF-α and myocardial matrix metalloproteinases in heart failure: Relationship to LV remodeling, Am J Physiol Heart Circ Physiol, 282, H1288, 10.1152/ajpheart.00526.2001
Lagyal, 2011, Prolonged mechanical ventilation among children with congenital heart disease undergoing cardiac surgery in philippine heart center: A risk factors analysis, Am J Respir Crit Care Med, 183, A1700
Hamid, 2009, Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: Role of nuclear factor-kappaB and inflammatory activation, Circulation, 119, 1386, 10.1161/CIRCULATIONAHA.108.802918
Wang, 2011, Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways, J Cell Biochem, 112, 1920, 10.1002/jcb.23112
